zonisamide has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 4 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zonisamide (ZNS) has proved effective for motor symptoms in PD and it may be also useful in the field of ICDs." | 1.36 | Zonisamide in managing impulse control disorders in Parkinson's disease. ( Anciones, B; Bermejo, PE; Ruiz-Huete, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kon, T | 1 |
| Ueno, T | 1 |
| Haga, R | 1 |
| Tomiyama, M | 1 |
| Bermejo, PE | 1 |
| Ruiz-Huete, C | 1 |
| Anciones, B | 1 |
| Tribó, MJ | 1 |
| Rozas-Muñoz, EA | 1 |
| Gallardo, F | 1 |
| Casanova, N | 1 |
| Ros-Montalban, S | 1 |
| Bulbena, A | 1 |
| Pujol, R | 1 |
| McElroy, SL | 1 |
| Kotwal, R | 1 |
| Keck, PE | 1 |
1 review available for zonisamide and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Comorbidity of eating disorders with bipolar disorder and treatment implications.
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Comorbidity; Disruptive, Impulse Cont | 2006 |
3 other studies available for zonisamide and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.
Topics: Adenosine A2 Receptor Antagonists; Age Factors; Aged; Antiparkinson Agents; Calcium Channel Blockers | 2018 |
Zonisamide in managing impulse control disorders in Parkinson's disease.
Topics: Aged; Antioxidants; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Isoxazoles; | 2010 |
Zonisamide for the treatment of self-inflicted dermatoses related to impulse control disorders.
Topics: Adolescent; Adult; Anticonvulsants; Disruptive, Impulse Control, and Conduct Disorders; Female; Huma | 2012 |